Benzodiazepine Prescribing from VA and Medicare to Dually Enrolled Older Veterans: A Retrospective Cohort Study
Tóm tắt
There has been a reduction in BZD prescribing in the Veterans Affairs (VA) health care system since 2013. It is unknown whether the decline in VA-dispensed BZDs has been offset by Medicare Part D prescriptions. To examine (1) whether, accounting for Part D, declines in BZD prescribing to older Veterans remain; (2) patient characteristics associated with obtaining BZDs outside VA and facility variation in BZD source (VA only, VA and Part D, Part D only). Retrospective cohort study with mixed effects multinomial logistic model examining characteristics associated with BZD source. A total of 1,746,278 Veterans aged ≥65 enrolled in VA and Part D, 2013–2017. BZD prescription prevalence and source. From January 2013 to June 2017, the quarterly prevalence of older Veterans with Part D filling BZD prescriptions through the VA declined from 5.2 to 3.1% (p<0.001) or, accounting for Part D, from 10.0 to 7.7% (p<0.001). Among those prescribed BZDs between July 2016 and June 2017, 37.0%, 10.2%, and 52.8% received prescriptions from VA only, both VA and Part D, or Part D only, respectively. Older age was associated with higher odds of obtaining BZDs through Part D (e.g., compared to those 65–74, Veterans ≥85 had adjusted odds ratio [AOR] for Part D vs. VA only of 1.8 [95% highest posterior density interval (HPDI), 1.69, 1.86]). Veterans with substance use disorders accounted for few BZD prescriptions from any source but were associated with higher odds of prescriptions through Part D (e.g., alcohol use disorder AOR for Part D vs. VA alone: 1.9 [95% HPDI, 1.63, 2.11]) The decline in BZD use by older Veterans with Part D coverage remained after accounting for Part D, but the majority of BZD prescriptions came from Medicare. Further reducing BZD prescribing to older Veterans should consider prescriptions from community sources.
Tài liệu tham khảo
Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001;57(5):419-425.
Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319(26):1701-1707.
Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine Use and Hip Fractures in the Elderly: Who Is at Greatest Risk? Arch Intern Med 2004;164(14):1567-1572.
Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 2012;29(8):639-658.
Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657-659.
Wisely AC. American Geriatrics Society: Ten Things Physicians and Patients Should Question. http://www.choosingwisely.org/societies/american-geriatrics-society/. Accessed August 2, 2017.
American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2019;67(4):674-694.
Maust DT, Kim HM, Wiechers IR, Ignacio RV, Bohnert ASB, Blow FC. Benzodiazepine Use among Medicare, Commercially Insured, and Veteran Older Adults, 2013-2017. J Am Geriatr Soc 2021;69(1):98-105.
Huang G, Kim S, Muz B, Gasper J. 2017 Survey of Veteran Enrollees’ Health and Use of Health Care. 2018. http://www.va.gov/HEALTHPOLICYPLANNING/SoE2017/VA_Enrollees_Report_Data_Findings_Report2.pdf Accessed on September 22, 2020.
Thorpe JM, Thorpe CT, Schleiden L, et al. Association between dual use of Department of Veterans Affairs and Medicare Part D drug benefits and potentially unsafe prescribing. JAMA Intern Med 2019;179(11):1584-1586.
Thorpe JM, Thorpe CT, Gellad WF, et al. Dual health care system use and high-risk prescribing in patients with dementia: a national cohort study. Ann Intern Med 2017;166(3):157-163.
Gellad WF, Thorpe JM, Zhao X, et al. Impact of dual use of Department of Veterans Affairs and Medicare Part D drug benefits on potentially unsafe opioid use. Am J Public Health 2018;108(2):248.
Moyo P, Zhao X, Thorpe CT, et al. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case–Control Study. Ann Intern Med 2019;170(7):433-442.
Centers for Medicare & Medicaid Services. Transition to Part D Coverage of Benzodiazepines and Barbiturates Beginning in 2013. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/BenzoandBarbituratesin2013.pdf Accessed May 6, 2016.
The Henry J. Kaiser Family Foundation. An Overview of the Medicare Part D Prescription Drug Benefit. https://www.kff.org/medicare/fact-sheet/an-overview-of-the-medicare-part-d-prescription-drug-benefit/. Accessed February 3, 2021.
The Henry J. Kaiser Family Foundation. An Overview of Medicare. https://www.kff.org/medicare/issue-brief/an-overview-of-medicare/ Accessed February 3, 2021.
Henderson M, MacGregor E, Sykes N, Hotopf M. The use of benzodiazepines in palliative care. Palliat Med 2006;20(4):407-412.
Maust DT, Lin LA, Goldstick JE, Haffajee RL, Brownlee R, Bohnert AS. Association of Medicare Part D benzodiazepine coverage expansion with changes in fall-related injuries and overdoses among Medicare advantage beneficiaries. JAMA Netw Open 2020;3(4):e202051-e202051.
Derrick B, Dobson-Mckittrick A, Toher D, White P. Test statistics for comparing two proportions with partially overlapping samples. J Appl Quant Methods. 2015;10(3).
U.S. Department of Veterans Affairs. Enrollment Priority Groups. https://www.va.gov/healthbenefits/resources/publications/IB10-441_enrollment_priority_groups.pdf. Published 2018. Accessed January 27, 2020.
van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009:626-633.
Ilgen MA, Kleinberg F, Ignacio RV, et al. Noncancer pain conditions and risk of suicide. JAMA Psychiatry 2013;70(7):692-697.
Goldstein H, Browne W, Rasbash J. Partitioning variation in multilevel models. Underst Stats 2002;1(4):223-231.
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2019. http://www.R-project.org/
Bürkner P. Advanced Bayesian Multilevel Modeling with the R Package brms. The R Journal 2018;10(1): 395-411.
Lin LA, Bohnert AS, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Impact of the opioid safety initiative on opioid-related prescribing in veterans. Pain. 2017;158(5):833-839.
Kullgren JT, Fagerlin A, Kerr EA. Completing the MISSION: a blueprint for helping veterans make the most of new choices. J Gen Intern Med 2020;35(5):1567-1570.
Carico R, Zhao X, Thorpe CT, et al. Receipt of overlapping opioid and benzodiazepine prescriptions among veterans dually enrolled in Medicare Part D and the Department of Veterans Affairs: a cross-sectional study. Ann Intern Med 2018;169(9):593-601.
Radomski TR, Zhao X, Thorpe CT, et al. VA and medicare utilization among dually enrolled veterans with type 2 diabetes: a latent class analysis. J Gen Intern Med 2016;31(5):524-531.
Liu CF, Batten A, Wong ES, Fihn SD, Hebert PL. Fee-for-Service Medicare-Enrolled Elderly Veterans Are Increasingly Voting with Their Feet to Use More VA and Less Medicare, 2003-2014. Health Serv Res 2018;53 Suppl 3:5140-5158.